Amasa Therapeutics pioneers revolutionary cell therapy for challenging cancers, aiming to transform patient care and overcoming some of the most persistent challenges in oncology.
Amasa Therapeutics is advancing the development of allogeneic cell therapy products as standalone immunotherapies designed to treat cancer with precision and durability. Looking ahead, we are also actively exploring synergistic strategies that combine our allogeneic cell therapy platform with autologous T cell-based therapies and oncolytic viruses, aiming to unlock even greater therapeutic potential and broaden clinical impact across a range of malignancies.
Our mission is to create and lead the revolution in cancer treatment by using an integrated approach of gene edited and engineered stem cells and nanomaterials products for solid tumors.
